Low relapse rate in younger patients ≤ 60 years old with newly diagnosed FLT3-mutated acute myeloid leukemia (AML) treated with crenolanib and cytarabine/anthracycline chemotherapy Meeting Abstract


Authors: Wang, E. S.; Tallman, M. S.; Stone, R. M.; Walter, R. B.; Karanes, C.; Jain, V.; Collins, R. H.
Abstract Title: Low relapse rate in younger patients ≤ 60 years old with newly diagnosed FLT3-mutated acute myeloid leukemia (AML) treated with crenolanib and cytarabine/anthracycline chemotherapy
Meeting Title: 59th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 130
Issue: Suppl. 1
Meeting Dates: 2017 Dec 9-12
Meeting Location: Atlanta, GA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2017-12-07
Language: English
ACCESSION: WOS:000432419401213
PROVIDER: wos
Notes: Meeting Abstract: 566 -- Source: Wos
MSK Authors
  1. Martin Stuart Tallman
    408 Tallman